4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-17-008213
Chief Scientific Officer sold 89,636 shares at $8.50 ($761,906)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2017-08-02 | Sale | −89,636 | $8.50 | $761,906 | 75,000 | D |
| Open-market sales · 89,636 sh · avg $8.50 · $761,906 | |||||||
Loading xslF345X03/f4080217kidron_oramed.xml…